Volta Medical, GE HealthCare Partner on Electrophysiology TechVolta Medical, GE HealthCare Partner on Electrophysiology Tech
The companies aim to address challenges when capturing and analyzing cardiac signals during AFib procedures.
.png?width=1280&auto=webp&quality=95&format=jpg&disable=upscale)
Volta Medical, a medtech company focused on artificial intelligence (AI) solutions to assist electrophysiologists, recently announced it has entered into a joint development agreement with GE HealthCare. The collaboration aims to integrate the Volta AF-Xplorer AI solution with GE’s Prucka 3 digital platform and CardioLab EP recording system.
Together the two companies’ products are expected to increase electrophysiologist performance and streamline workflow during catheter ablation procedures to treat atrial fibrillation (AFib), according to the press release.
"Our mission to combat complex heart rhythm diseases relies on optimizing interoperability,” said Théophile Mohr-Durdez, CEO and co-founder of Volta Medical, in the release. “Through this collaboration with GE HealthCare, we are advancing the frontier of current clinical applications in the field of electrophysiology. To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.”
The AF-Xplorer is designed to assist electrophysiologists in the real-time assessment of specific abnormal electrograms (EGMs) known as spatio-temporal dispersed EGMs during AFib and atrial tachycardia procedures. The AI solution then aligns with GE’s CardioLab EP recording systems signal clarity, helping better visualize small physiological signals. The system incorporates standardized point-of-care collection and entry with minimal training to support workplace efficiency, according to GE HealthCare. Part of the CardioLab system, the Prucka 3 digital amplifier significantly reduces noise, maintains high signal fidelity, and provides new signal-filtering capabilities.
“Electrophysiology labs play a pivotal role in the treatment of cardiac arrhythmias like AFib and require sophisticated recording systems to capture and analyze intracardiac signals accurately,” Devon Bream, general manager of invasive Cardiology for GE HealthCare, told MD+DI. “To help address challenges clinicians face in analyzing these cardiac signals, we’re looking at how we can use the vast amounts of data available more effectively at the point of care. Volta Medical’s AI-driven solutions hold so much promise in how they can help consolidate and simplify data to assist clinicians. We're excited about our ongoing collaboration aimed at innovating and transforming electrophysiology labs to help clinicians provide patients the best possible care.”
Marked as a key initiative for Volta, the collaboration comes after the company recently presented positive TAILORED-AF trial results and focuses on the early commercialization efforts and the completion of its RESTART clinical trial.
About the Author
You May Also Like